Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026)
Ascendis Pharma A (ASND) reported Asset Utilization Ratio of 0.62 for Q1 2026, up 158.25% on a YoY basis from 0.24 in Q1 2025, and down 12.49% sequentially from 0.71 in Q4 2025.
Ascendis Pharma A (ASND) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 12 years of Asset Utilization Ratio data on file, last reported at 0.62 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 158.25% year-over-year to 0.62; the trailing twelve-month figure through Mar 2026 stood at 0.62 (up 158.25% YoY), and the FY2025 full-year result was 0.34, up 66.69% from the prior year.
- Asset Utilization Ratio eased to 0.62 in Q1 2026, from 0.71 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.71 in Q4 2025 to a low of 0.04 in Q4 2022.
- A 5-year average of 0.35 and a median of 0.24 in 2025 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio jumped 1044.42% in 2023 and slumped 60.25% in 2025, its largest moves.
- Tracing ASND's Asset Utilization Ratio over 5 years: stood at 0.04 in 2022, then jumped by 1044.42% to 0.51 in 2023, then sank by 53.46% to 0.24 in 2024, then jumped by 201.82% to 0.71 in 2025, then decreased by 12.49% to 0.62 in 2026.
- Business Quant data shows ASND's Asset Utilization Ratio at 0.62 in Q1 2026, 0.71 in Q4 2025, and 0.67 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 0.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.71 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.58 |
| Mar 31, 2025 | 0.24 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | 0.53 |
| Jun 30, 2024 | 0.62 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.51 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.08 |